S

Sophia Genetics SA
NASDAQ:SOPH

Watchlist Manager
Sophia Genetics SA
NASDAQ:SOPH
Watchlist
Price: 3.31 USD 1.53% Market Closed
Market Cap: 216.4m USD
Have any thoughts about
Sophia Genetics SA?
Write Note

Sophia Genetics SA
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sophia Genetics SA
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
S
Sophia Genetics SA
NASDAQ:SOPH
Additional Paid In Capital
$471.8m
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ascom Holding AG
SIX:ASCN
Additional Paid In Capital
CHf1.1m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
No Stocks Found

Sophia Genetics SA
Glance View

Market Cap
219.9m USD
Industry
Health Care

SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. The firm offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The firm has offices in Switzerland, France and the United Kingdom and operates worldwide.

SOPH Intrinsic Value
4.3 USD
Undervaluation 23%
Intrinsic Value
Price
S

See Also

What is Sophia Genetics SA's Additional Paid In Capital?
Additional Paid In Capital
471.8m USD

Based on the financial report for Dec 31, 2023, Sophia Genetics SA's Additional Paid In Capital amounts to 471.8m USD.

What is Sophia Genetics SA's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 3Y
28%

Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Sophia Genetics SA have been 28% over the past three years .

Back to Top